Theravance Biopharma, Inc. - Ordinary Share $0.00001 Par Value (TBPH)

CUSIP: G8807B106

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class
Equity / Ordinary Share $0.00001 Par Value
Shares outstanding
51,428,000
Total 13F shares
64,209,180
Share change
+1,321,837
Total reported value
$581,714,921
Put/Call ratio
100%
Price per share
$9.06
Number of holders
106
Value change
+$11,702,533
Number of buys
44
Number of sells
57

Security key

G8807B106

Report period

Q2 2022

Institutions

106

Top holders

10

Top shareholders of TBPH - Theravance Biopharma, Inc. - Ordinary Share $0.00001 Par Value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
BAUPOST GROUP LLC/MA
13F
Company
27%
13,643,333
$130,430,000 31 Mar 2022
13F
Madison Avenue Partners, LP
13F
Company
14%
7,269,584
$69,497,223 31 Mar 2022
13F
VANGUARD GROUP INC
13F
Company
14%
6,947,947
$66,421,000 31 Mar 2022
13F
Weiss Asset Management LP
13F
Company
11%
5,412,487
$51,743,000 31 Mar 2022
13F
BlackRock Finance, Inc.
13F
Company
9.6%
4,929,140
$47,123,000 31 Mar 2022
13F
ORBIMED ADVISORS LLC
13F
Company
6.3%
3,254,713
$31,115,000 31 Mar 2022
13F
FMR LLC
13F
Company
5.2%
2,694,912
$25,763,000 31 Mar 2022
13F
STATE STREET CORP
13F
Company
3%
1,541,533
$14,737,000 31 Mar 2022
13F
Newtyn Management, LLC
13F
Company
2.7%
1,375,000
$13,145,000 31 Mar 2022
13F
Woodline Partners LP
13F
Company
2.6%
1,326,653
$12,683,000 31 Mar 2022
13F
D. E. Shaw & Co., Inc.
13F
Company
2.4%
1,239,042
$11,845,000 31 Mar 2022
13F
Chescapmanager LLC
13F
Company
2.3%
1,166,574
$11,152,000 31 Mar 2022
13F
JACOBS LEVY EQUITY MANAGEMENT, INC
13F
Company
2%
1,041,954
$9,961,000 31 Mar 2022
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
2%
1,010,163
$9,657,000 31 Mar 2022
13F
GOLDMAN SACHS GROUP INC
13F
Company
1.9%
976,373
$9,335,000 31 Mar 2022
13F
MORGAN STANLEY
13F
Company
1.3%
669,945
$6,405,000 31 Mar 2022
13F
BANK OF AMERICA CORP /DE/
13F
Company
1.3%
668,888
$6,395,000 31 Mar 2022
13F
Point72 Asset Management, L.P.
13F
Company
1.3%
656,100
$6,272,000 31 Mar 2022
13F
NORTHERN TRUST CORP
13F
Company
1.1%
589,053
$5,631,000 31 Mar 2022
13F
NORGES BANK
13F
Company
1%
533,094
$5,096,379 31 Mar 2022
13F
Frank Pasqualone
3/4/5
SVP, CHIEF BUSINESS OFFICER
class O/S missing
429,783
$4,422,467 19 Nov 2021
Kenneth R. Pitzer
3/4/5
SVP, PROD STRAT & COMM PLNG
class O/S missing
380,123
$3,911,466 18 Feb 2022
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.78%
402,640
$3,850,000 31 Mar 2022
13F
Philip D. Worboys
3/4/5
SVP, RESEARCH & TRANSL SCIENCE
class O/S missing
330,752
$3,403,438 19 Nov 2021
Park West Asset Management LLC
13F
Company
0.66%
340,000
$3,250,000 31 Mar 2022
13F
VOLORIDGE INVESTMENT MANAGEMENT, LLC
13F
Company
0.65%
335,106
$3,204,000 31 Mar 2022
13F
Bradford J. Shafer
3/4/5
EVP, Gen. Counsel, Secretary
class O/S missing
277,831
$2,858,881 20 Aug 2021
PANAGORA ASSET MANAGEMENT INC
13F
Company
0.53%
270,691
$2,588,000 31 Mar 2022
13F
Vijay Sabesan
3/4/5
SVP, TECHNICAL OPERATIONS
class O/S missing
235,524
$2,423,542 19 Nov 2021
MACQUARIE GROUP LTD
13F
Company
0.42%
214,712
$2,053,000 31 Mar 2022
13F
PDT Partners, LLC
13F
Company
0.37%
192,701
$1,842,000 31 Mar 2022
13F
Bank of New York Mellon Corp
13F
Company
0.37%
189,697
$1,813,000 31 Mar 2022
13F
Nuveen Asset Management, LLC
13F
Company
0.36%
186,906
$1,811,000 31 Mar 2022
13F
PICTET ASSET MANAGEMENT SA
13F
Company
0.36%
186,784
$1,786,000 31 Mar 2022
13F
AXA S.A.
13F
Company
0.36%
186,500
$1,782,940 31 Mar 2022
13F
JPMORGAN CHASE & CO
13F
Company
0.34%
173,292
$1,656,000 31 Mar 2022
13F
Cubist Systematic Strategies, LLC
13F
Company
0.3%
154,485
$1,477,000 31 Mar 2022
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.29%
149,240
$1,427,000 31 Mar 2022
13F
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
0.29%
148,387
$1,419,000 31 Mar 2022
13F
First Pacific Advisors, LP
13F
Company
0.27%
139,774
$1,336,000 31 Mar 2022
13F
Swiss National Bank
13F
Company
0.25%
130,642
$1,249,000 31 Mar 2022
13F
BNP PARIBAS FINANCIAL MARKETS
13F
Company
0.24%
124,234
$1,187,677 31 Mar 2022
13F
JANE STREET GROUP, LLC
13F
Company
0.24%
123,334
$1,180,000 31 Mar 2022
13F
King Wealth Management Group
13F
Company
0.24%
122,000
$1,166,000 31 Mar 2022
13F
CM Management, LLC
13F
Company
0.23%
120,000
$1,147,000 31 Mar 2022
13F
Ann Brady
3/4/5
PRESIDENT, TBIL
class O/S missing
110,319
$1,135,183 18 Feb 2022
Brandywine Global Investment Management, LLC
13F
Company
0.22%
111,100
$1,062,000 31 Mar 2022
13F
PUTNAM INVESTMENTS LLC
13F
Company
0.2%
105,294
$1,007,000 31 Mar 2022
13F
William D. Young
3/4/5
Director
mixed-class rows
106,010
mixed-class rows
$802,723 26 Apr 2022
ALLIANCEBERNSTEIN L.P.
13F
Company
0.15%
77,735
$743,000 31 Mar 2022
13F

Institutional Holders of Theravance Biopharma, Inc. - Ordinary Share $0.00001 Par Value (TBPH) as of Q2 2022

As of 30 Jun 2022, Theravance Biopharma, Inc. - Ordinary Share $0.00001 Par Value (TBPH) was held by 106 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 64,209,180 shares. The largest 10 holders included BAUPOST GROUP LLC/MA, Madison Avenue Partners, LP, VANGUARD GROUP INC, Weiss Asset Management LP, BlackRock Inc., Park West Asset Management LLC, FMR LLC, Woodline Partners LP, Newtyn Management, LLC, and STATE STREET CORP. This page lists 107 institutional shareholders reporting positions in this security for the Q2 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2022 vs Q1 2022 Across Filers

Q1 2022 holders
114
Q2 2022 holders
106
Holder diff
-8
Investor Q1 2022 Shares Q2 2022 Shares Share Diff Share Chg % Q1 2022 Value $ Q2 2022 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .